After Moody’s revised its outlook for the United States government from stable to negative, investors are watching the Federal Reserve to see where it will take rates next. Former Kansas City Fed President Esther George share’s her thoughts on the Fed's decision to keep their options open on rate hikes and her observations on signs of economic cooling. Plus, Novo Nordisk’s weight loss drug Wegovy cut the risk of serious cardiovascular complications in people with obesity and heart disease. Dr. Angela Fitch, Chief Medical Officer of Knownwell and President of the Obesity Medicine Association, joins to delve into the latest study on Wegovy, exploring its implications for the obesity epidemic in the U.S., and more.